Attached files

file filename
EX-4.3 - EX-4.3 - Inspire Medical Systems, Inc.a2235314zex-4_3.htm
EX-10.21 - EX-10.21 - Inspire Medical Systems, Inc.a2235314zex-10_21.htm
EX-10.19 - EX-10.19 - Inspire Medical Systems, Inc.a2235314zex-10_19.htm
EX-10.17 - EX-10.17 - Inspire Medical Systems, Inc.a2235314zex-10_17.htm
EX-10.15 - EX-10.15 - Inspire Medical Systems, Inc.a2235314zex-10_15.htm
EX-10.13 - EX-10.13 - Inspire Medical Systems, Inc.a2235314zex-10_13.htm
EX-10.12 - EX-10.12 - Inspire Medical Systems, Inc.a2235314zex-10_12.htm
EX-10.11 - EX-10.11 - Inspire Medical Systems, Inc.a2235314zex-10_11.htm
EX-5.1 - EX-5.1 - Inspire Medical Systems, Inc.a2235314zex-5_1.htm
EX-4.1 - EX-4.1 - Inspire Medical Systems, Inc.a2235314zex-4_1.htm
EX-3.6 - EX-3.6 - Inspire Medical Systems, Inc.a2235314zex-3_6.htm
EX-3.5 - EX-3.5 - Inspire Medical Systems, Inc.a2235314zex-3_5.htm
EX-3.3 - EX-3.3 - Inspire Medical Systems, Inc.a2235314zex-3_3.htm
EX-1.1 - EX-1.1 - Inspire Medical Systems, Inc.a2235314zex-1_1.htm
S-1/A - S-1/A - Inspire Medical Systems, Inc.a2235314zs-1a.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated February 14, 2018 (except for the effect of the reverse stock split discussed in the third paragraph of Note 13 to the financial statements, as to which the date is April 23, 2018), in Amendment No. 1 to the Registration Statement (Form S-1 333-224176) and related Prospectus of Inspire Medical Systems, Inc. dated April 23, 2018.

 

/s/ Ernst & Young LLP

 

Minneapolis, MN

April 23, 2018